On March 18, 2022, Pfizer filed a 45 page opposition to the KEI application for a compulsory license on Paxlovid patents in the Dominican Republican. This is the Pfizer filing, and KEI’s unofficial translation.
Pfizer-opposition-DR-CL-18March2022.pdf
Translation-Pfizer-opposition-KEI-CL-Paxlovid-18march2022.pdf
The December 3, 2021 KEI petition for a compulsory license is here: https://www.keionline.org/37066